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Gene Editing and the
Designer Babies

Rise

of

ABSTRACT

Nearly as long as human beings have existed on this earth,
many people have sought out the ideal of perfecting their
population: infanticide in Sparta during the Hellenistic era;
compulsory sterilization in the 1920s in the United States; and
the unimaginable atrocities of the Holocaust in the 1940s in
Europe. The goal of alleged perfection leaves many hesitant to
repeat the mistakes of our past. Today, a new frontier of science
has emerged, gene editing using CRISPR-Cas9, reignitingethical
debate as to how far humans should go in manipulating the
population.
While many proponents herald this technology as a potential
for eradicatingdevastatinggenetic disease, some criticsfear that
it presents an opportunity to pre-select "desirable" traits in
offspring, which is expounded by a lack of clear scientific and
ethical regulations in the United States and abroad. Though the
NationalAcademies of Science and Medicine recently began an
initiativeto address the implicationsof this technology, this body
can only provide a recommendation. This Note looks to the
technology, historical eugenics' concerns, domestic and foreign
law, and the recommendations of the Academies, in proposing a
two-part solution to address the concerns surrounding "designer
babies" reinforcing United States research laws and revising the
Universal Declaration on the Human Genome and Human

Rights.
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I. INTRODUCTION

Like the genetically "perfect" society in the film Gattacal or the
genetically modified "Indominus Rex" in Jurassic World,2 gene editing
inundates popular culture. 3 How can science make individuals
stronger, eradicate disease, and obtain societal perfection? While such
concepts seem best suited for the science-fiction genre, editing human
genes is no longer a hypothetical scenario. Rather, the reality of
modern gene editing now focuses not on whether science could

GATTACA (Jersey Films 1997).
1.
2.
JURASSIC WORLD (Amblin Entertainment, Legendary Pictures 2015).
3.
This Note uses "gene editing" or "genetic modification" to refer to the
narrower concept of genome editing or human germline gene editing, also referred to as
human germline modification, "deliberating changing the genes passed on to children
and future generations. . . .". About Human Germline Gene Editing, CTR. FOR GENETICS
AND Soc'Y, http://www.geneticsandsociety.org/article.php?id=8711 (last visited Feb. 6,
2017) [https://perma.cc/PYZ9-RYQJ] (archived Feb. 6, 2017).
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genetically "perfect" an individual, but instead, whether science should
do so.
Modern gene editing evolved, in part, from a variety of scientific
advancements in embryonic research. Previously, gene editing
conversations, in terms of potential offspring, often centered on the
techniques of pre-implantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD)-two techniques physicians use
during in vitro fertilization (IVF) to achieve pregnancy in patients. 4
These processes screen "embryos for genetic predispositions to rare
disorders as well as prevalent and treatable diseases.

.

.

."s

The

screening results determine whether abnormalities are present in the
embryos and allow the prospective parents to determine whether to
implant specific embryos. 6
On the one hand, the advantage of such technology is obvious: it
eliminates much of the risk of having a child born with a devastating
debilitating disease,7 which could present the parents with an
unanticipated emotional and/or financial hardship. On the other hand,
some critics argue that purposefully avoiding the implantation of
embryos that are genetically predisposed to evolve into a child with a
disability only perpetuates misconceptions that individuals with
disabilities have a lesser quality of life. 8 Despite this discord among

For a background on Preimplantation Genetic Diagnosis and Screening,
4.
including its uses and limitations, see Jaime King, Predicting Probability:Regulating
the Future of PreimplantationGenetic Screening, 8 YALE J. HEALTH POL'Y & ETHICS 283,
290-301 (2008).
Gregory Katz & Stuart 0. Schweitzer, Implications of Genetic Testing for
5.
Health Policy, 10 YALE J. HEALTH POL'Y L. & ETHICS 90, 93 (2010).
See King, supra note 4, at 291 ("After getting the test results, the clinician
6.
usually transfers two to three embryos that meet the parents' approval to the uterus in
hopes of establishing pregnancy. Embryos with undesired genes are typically discarded
or donated to research.").
See, e.g., JOYCE HARPER, PREIMPLANTATION GENETIC DIAGNOSIS 151 (2d ed.
7.
2009):
PGD, followed by implantation of disease-free embryos, offers couples at high
risk of transmitting a serious genetic disorder a possibility of seriously
diminishing or avoiding the risk of disease in their offspring. Also, couples at
high risk for (repeated) spontaneous pregnancy loss because of a structural
chromosome abnormality in one of the spouses may benefit from PGD. Finally,
many couples opt for PGD because they experience a combined genetic and
fertility problem and require medically assisted reproduction anyway.
Several groups have criticized PGD for a variety of reasons. Feminists feared
8.
women would be prosecuted for declining the technology or that a child born with
disabilities could sue his or her mother for failing to undergo testing. Additionally,
disability activists and scholars worry that the technology may continue "to perpetuate
negative myths about the quality of life for people with disabilities and their families."
See Kimberly M. Mutcherson, Making Mommies: Law, Pre-Implantation Genetic
Diagnosis, and the Complications of Pre-Motherhood, 18 COLUM. J. GENDER & L. 313,
324 (2008).
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bioethicists and disability activists in this arena, gene editing has
moved beyond the immensely complex area of disability prevention to
include the pre-selection of a child's gender by determining the sex
prior to implantation. 9 Still the most astonishing recent development
occurred in April 2015, when Chinese scientists revealed that they
used a -new technology known as CRISPR-Cas9 to, for the first time,
edit deoxyribose nucleic acid (DNA) in human embryos.1 0
With such capabilities, many critics of the CRISPR-Cas9
technology are concerned that it will eventually lead to a market for
designer babies, children whose traits, including height, eye color, and
even athletic ability, are pre-selected by their parent-consumers. 11 In
discussing the implications of this technology, bioethicist George
Annas noted that "[w]hen we talk about [sic] 'better,' we're making very
real value judgments about our genetic code and its worth."1 2 Perhaps
shockingly to some, such a concern is not just theoretical conjecture. In
one study, 12 percent of parents surveyed claimed they would abort a
fetus that was predisposed to being obese.' 3
The international community lacks uniformity in regulating geneediting technology, no more so than the three countries at the forefront
of the discussion. In 2015, within the confines of a federal spending bill,
the U.S. Congress effectively prohibited such technology in federallyfunded research.1 4 The United Kingdom, by contrast, formally granted

9.
See Gautam Naik, A Baby, Please. Blond, Freckles - Hold the Colic, WALL
ST. J. (Feb. 12, 2009, 12:01 AM), http://www.wsj.com/articles/SB123439771603075099
[https://perma.cc/2ZKL-9AF2] (archived Jan. 22, 2017) (discussing a Los Angeles clinic
claiming that it would be offering couples the ability to pick gender and certain physical
attributes for their future children).
10.
David Cyranoski & Sara Reardon, Chinese Scientists Genetically Modify
Human Embryos, NATURE (Apr. 22, 2015), http://www.nature.com/news/chinesescientists-genetically-modify-human-embryos- 1.17378
[https://perma.cc/JTE9-ESAC]
(archived Jan. 22, 2017).
11.
See Rob Stein, British Scientists Seek Permission To Edit DNA In Human
Embryos, NPR (Sept. 18, 2015 11:44 AM), http://www.npr.org/sections/health-shots/2015/
09/18/441408880/british-scientists-seek-permission-to-edit-dna-in-human-embryos [https://
perma.cclH6E7-SXMQ] (archived Jan. 22, 2017) ("Critics say that could open the door to
accidentally introducing a new disease or to trying to genetically engineer the human
race and create 'designer babies,' in which parents pick the traits of their children.").
12.
Kevin Loria, It's Time for an Uncomfortable Discussion about What it Really
Means to Engineer a 'Designer Baby, BuS. INSIDER AuSTL. (Aug. 13, 2015, 12:49
AM), http://www.businessinsider.com.aulwhat-the-designer-baby-discussion-really-means2015-8 [https://perma.cc/6Q5N-76QZ] (archived Jan. 22, 2017).
13.

LORI B. ANDREWS ET AL., GENETICS: ETHICS LAW AND POLICY 247 (4th ed. 2015).

14.
See Mike Orcutt, The Unintended Consequences of Congress's Ban on
Designer Babies, TECH. REv. (Aug. 26, 2016), https://www.technologyreview.com/s/602219/
the-unintended-consequence-of-congresss-ban-on-designer-babies/ [https://perma.cc/53B25D8M] (archived Jan. 22, 2017) (discussing the effects of the United States' regulation of
gene-editing techniques); see also Consolidated Appropriations Act of 2016, Pub. L. No.
114-113, § 749, 129 Stat. 2283 (2015) ("None of the funds made available by this Act may
be used.. . in research in which a human embryo is intentionally created or modified to
include a heritable genetic modification.").
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Kathy Niakan of the Francis Crick Institute in London permission to
conduct gene-editing research in human embryos. 15 The research team
underwent two separate approval processes, one from the Human
Fertilisation and Embryology Authority in February 2016, and one
from the National Health Service Health Research Authority in May
2016.16 Meanwhile, the country that sparked the recent designer-baby
conversation, China, remains limited only by non-binding national
guidelines prohibiting "the implantation of modified human embryos
for reproductive purposes since 2003.""

Such rapidly changing technological advances and the lack of an
international consensus on how to regulate these advances have moved
science and society into uncharted territory. Consequently, in
December of 2015, the United States National Academy of Sciences
and the National Academy of Medicine, along with the Chinese
Academy of Sciences and the Royal Society of the United Kingdom,
hosted the International Summit on Human Gene Editing
(International Summit), "conven[ing] experts from around the world to
discuss the scientific, ethical, and governance issues associated with
human gene-editing research."' 8 Upon concluding the International
Summit, the second phase, a consensus study, commenced, which
resulted in a report that came out in February 2017.19 This study
demonstrates the importance of international uniformity and
cooperation in determining the scientific and ethical limits of the
technology, and the study may act as a tool to guide the future
development of gene-editing regulations.
This Note conducts a comparative analysis of foreign law and,
more importantly, critiques the current lack of an international
consensus. Part II provides an overview of the CRISPR-Cas9
technology and its potential benefits, as well as the varying opinions in
the scientific community of the technology's capabilities. Part III

Fergus Walsh, Gene editing technique could transform future, BBC HEALTH
15.
(June 6, 2016), http://www.bbc.comlnews/health-36439260 [https:I/perma.cc/8VEY-JJLB]
(archived Jan. 22, 2017).
See Ben Spencer, British scientists will genetically modify embryos by the end
16.
of the year in bid to understand why women miscarry, DAILY MAIL (May 27,
2016), http://www.dailymail.co.uk/health/article-3613080/British-scientists-geneticallymodify-embryos-end-year-bid-understand-women-miscarry.html [https://perma.cc/2UQ6KTFW] (archived Jan. 22, 2017) (outlining the approval process and research of the
Francis Crick Institute and anticipated upcoming research).
See Douglas Sipp & Duanqing Pei, Comment: Bioethics in China: No wild east,
17.
534 NATURE 465 (June 22, 2016), http://www.nature.com/news/bioethics-in-china-no-wildeast-1.20116 [https://perma.cc/SMY3-Y68Y] (archived Jan. 22, 2017) (discussing the
perception that China is without regulation for embryonic-stem-cell research).
18.

International

Summit,

NAT'L

AcADS.

SCIs.,

http://nationalacademies.org/gene-editing/Gene-Edit-Summit/ (last
2017) [https://perma.cc/5V8M-AFXX] (archived Jan. 26, 2017).
19.
Id.

ENG'G,

visited

&

MED.,

Jan.

26,
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briefly discusses some of the ethical concerns surrounding gene editing
by looking at two of the more infamous eugenics movements, the forced
sterilization laws of the early 1900s in the United States and Hitler's
attempt to promote a "superior race" in Nazi Germany. Part IV
compares the current gene-editing laws in the United States, the
United Kingdom, and China in order to illustrate the legal variance
and complexity in regulations among nations. Part V then discusses
the International Summit and Consensus Study of the National
Academies of Science.
In recognizing the variance in the international regulations,
concerns of the scientific community, and ambiguity in the Academies'
recommendation, Part VI proposes a two-part solution to remedy the
lack of enforceable gene-editing regulations, both within the United
States and internationally. First, the United States should revise its
laws to promote the progress of scientific research in this field while
restricting ethical concerns. Second, given the administrative
difficulties in enacting a binding treaty and the current political
climate, a more flexible mechanism for establishing an international
consensus should be employed: the revision of the Universal
Declaration on the Human Genome and Human Rights.
II. THE CRISPR-CAS9 TECHNOLOGY: BACKGROUND, BENEFITS, AND
LIMITATIONS

CRISPR-Cas9 inundates current news coverage in both the
scientific and mainstream media. A simple Google search of "CRISPRCas9" as of January 2017 will render some 481,000 results, 20 and the
technology has even appeared on popular television shows. In the
series finale of the "X-Files" reboot, CRISPR-Cas9 played a role in a
dramatic alien conspiracy. 21 While a CRISPR-Cas9 alien conspiracy
may seem laughable to many, the fear of the rise of designer babies
does not, creating tension and debate among scientific scholars and
ethicists. David King, director of Human Genetics Alert, claims that
permitting the use of this technology in research experiments "is the
first step in a well mapped-out process leading to [genetically edited]
babies, and a future of consumer eugenics." 22 But, supporters of the
technology believe that the information gained from further CRISPR-

20.
Author search of "CRISPR-Cas9" conducted on January 26, 2017.
21.
Rebecca Harrington, The creator of 'The X-Files' says this is the coolest real
science fact he learned from the reboot, Bus. INSIDER (June 9, 2016, 1:07 PM),
http://www.businessinsider.com/x-files-creator-chris-carter-crispr-2016-6 [https://perma.cc/
EWN9-MTVQ] (archived Jan. 26, 2017) (discussing how the recent season of X-Files tied
CRISPR-Cas9 technology into its alien conspiracy plotline).
22.
James Gallagher, Scientists get "gene editing"go-ahead,BBC (Feb. 1, 2016),
http://www.bbc.com/news/health-35459054
[https://perma.cc/L3NT-6FXB]
(archived
Jan. 26, 2017).
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Cas9 research will provide invaluable insight as to which genes are
vital for healthy development in humans. 23 In order to address the
disagreement, this Part first briefly describes the CRIPSR-Cas9
technology, then looks at its purported benefits, and finally discusses
the debate among scientists as to the limitations of the technology.
A. The CRISPR-Cas9 Technology and Gene Editing
CRISPR, Clustered Regulatory Interspaced Short Palindromic
Repeats, are a critical component of an individual's defense system
against bacteria. 24 In simplistic terms, CRISPR contain "sequences of
genetic code," which include interim sequences known as spacer.
sequences, which code for past bacterial invaders in the body. 25 These
spacer sequences help "the cell detect and destroy [past bacterial]
invaders" upon their return, 26 with CRISPR acting as a guide to
specific sequence of DNA. 27 Cas9, "a CRISPR-associated protein...
that is programmed by small [ribonucleic acids] to cleave DNA," 28
commences the actual gene editing. It binds to the sequence of DNA of
29
interest "and cuts it, shutting the targeted gene off."

Scientists are able to program these sequences so precisely that
commentators have likened the technology "to a word processor,
capable of effortlessly editing a gene down to the level of a single
letter."30 CRISPR can find the right sequence even when searching
through billions of DNA pairs, and can do so extremely accurately.3 1

23.
See JV Chamary, GM Human Embryos Won't Create Designer Babies,
FORBES (Feb. 16, 2016, 10:00 AM), http://www.forbes.com/sites/jvchamary/2016/02/16/
embryo-gene-editing/#563151661e40 [https://perma.cc/9AZM-YGXC] (archived Jan. 26,
2017) (quoting Dr. Kathy Niakan of the Francis Crick Institute in London to whom the
United Kingdom Human Fertilisation and Embryology Authority recently granted a
license in order td edit genes in embryos).
24.
Questions
and
Answers
About
CRISPR,
BROAD
INST.,
https://www.broadinstitute.org/what-broadlareas-focus/project-spotlight/questions-andanswers-about-crispr (last visited Jan. 26, 2017) [https:I/perma.cc/9WXY-95BP]
(archived Jan. 26, 2017).
Id.
25.
26.
Id.
27.
Id.
Alex Reis et al., CRISPR/Cas9 and Targeted Genome Editing:A New Era in
28.
Molecular Biology, NEW ENGLAND BIOLABS INC. (2014), https://www.neb.com/tools-andresources/feature-articles/crispr-cas9-and-targeted-genome-editing-a-new-era-in-molecularbiology [https://perma.ccY9YR-LQVC] (archived Feb. 19, 2017).
BROAD INST., supra note 24.
29.
Jennifer Kahn, The Crispr Quandary, N.Y. TIMES (Nov. 9, 2015),
30.
http://www.nytimes.com/2015/11/15/magazine/the-crispr-quandary.html?_r=0 [https://
perma.cc/7JFS-BQ4N] (archived Jan. 26, 2017).
31.
Robert Sanders, CRISPR-Cas9 gene editing: check three times, cut once,
BERKELEY NEWS (Nov. 12, 2015), http://news.berkeley.edul2015/11/12/crispr-cas9-gene-
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Further, the Cas9 editing process is believed to have three different
checks to ensure the correct gene is cut out.3 2 First is the precursory

scan, discussed above, which allows Cas9 to locate the appropriate
gene. The second check corrects possible errors from Cas9 binding to
incorrect genes. The Cas9 protein binds on to the DNA base pairs only
when they precisely match the RNA base pairs of the Cas9.3 3 If

incorrect binding occurs, it only lasts for "milliseconds to seconds before
the Cas9 moves on" to the correct match. 34 Finally, since some incorrect
matches can occur, particularly to off-target sequences that only differ
by a few mutations, the actual cutting will only occur if there is a
precise match with the DNA sequence, otherwise the Cas9 protein
inhibits it.35 However, despite these checks, researchers have faced
difficulty in using the technology precisely enough to prevent
unintended edits through incorrect binding. 36
Alleviating some of the fear of incorrect binding, scientists
recently discovered an "off-switch" for CRISPR-Cas9: "anti-CRISPR
proteins" that can be used to turn off gene edits.3 7 The ability to turn
off edits could provide researchers with "a fail-safe to quickly block any
potential harmful uses of the technology." 38 While researchers are
continuing to unwind the intricacies of this technology, it nonetheless
has the potential to revolutionize the scientific and medical fields. Yet
with such revolutionary capabilities, the debate now centers on what
diseases CRISPR-Cas9 could alleviate and when researchers will be
ready to use the technology.
B. Benefits of CRISPR-Cas9
CRISPR-Cas9 has the potential to change the world. From a
clinical standpoint, since there are over six thousand diseases linked
to genes, the technology could have vast implications for the overall
human population.3 9 Researchers, and even organizations tied to

editing-check-three-times-cut-once/ [https://perma.ccZ4QR-7YF8] (archived Jan. 26,
2017).
32.
Id.
33.
Id.
34.
Id.
35.
Id.
36.
Off-switch for CRISPR-Cas9gene editing system discovered, PHYS.ORG (Dec.
29, 2016), https://phys.org/news/2016-12-off-switch-crispr-cas9-gene.html [https://perma.cc/
CTN4-9U2F] (archived Jan. 26, 2017).
Id.
37.
Id.
38.
39.
See Simon Wilson, Gene editing: A Cut-and-Paste Cure for Cancer,
MONEYWEEK (Nov. 14, 2014), http://moneyweek.com/gene-editing-a-cut-and-paste-curefor-cancer/ [https://perma.cc/AYM2-5Z96] (archived Jan. 26, 2017) (noting that "gene
editing's scope could be vast" given the number of genetics-based diseases).
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specific genetic diseases, are consequently working to determine if
CRISPR-Cas9 will provide long-awaited treatments and cures.
One example of an area for treatment is cystic fibrosis, a disease
caused by a gene mutation "that causes persistent lung infections and
limits the ability to breathe over time." 40 Possible treatment would use
the CRISPR-Cas9 technology to replace the mutated gene with the
correct one, 41 although there are nearly 1,800 mutations in the cystic
fibrosis gene. 42 The Cystic Fibrosis Foundation Therapeutics,
associated with the Cystic Fibrosis Foundation, entered into an
agreement with Editas Medicine to provide Editas up to $5 million to
develop a medicinal treatment. 43 Preliminary studies in intestinal
stem cells have shown promise. 44 Another example is CRISPR-Cas9's
promising potential for treating hemophilia, a well-known blood
disorder that causes excessive bleeding. Like cystic fibrosis, genetic
mutations in an individual's DNA cause hemophilia. 45 Researchers at
the University of Pennsylvania developed a treatment for hemophilia
using CRISPR-Cas9 and delivered it to hemophilic mice. 46 The
preclinical study results demonstrated that this treatment method
may be translatable to treat hemophilia in humans. 47
C. Debate among the Scientific Community
While CRISPR-Cas9 may revolutionize the way the scientific
community approaches, and the medical community treats genetic
diseases, some critics fear that the technology will usher in a
generation of designer babies and "a dystopia of superpeople."4 8 On the
one hand, it is relatively easy to understand society's unease about the
extreme scenarios that could result from CRISPR-Cas9 gene editing,

40.
About Cystic Fibrosis, CYSTIC FIBROSIS FOUND., https://www.cff.org/What-isCF/About-Cystic-Fibrosis/ (last visited Jan. 26, 2017) [https://perma.cc/9M6D-G75T]
(archived Jan. 26, 2017).
41.
CRISPR/Cas9 Approach for Cystic Fibrosis Treatment, CYSTIC FIBROSIS
NEWS TODAY, https://cysticfibrosisnewstoday.com/crisprcas9-approach-for-cystic-fibrosis/
(last visited Jan. 26, 2017) [https://perma.cc/9LWF-ATBK] (archived Jan. 26, 2017).
42.
Id.
43.
Id.
44.
Id. (noting that a recent study used "a model of intestinal stem cell organoids
from [cystic fibrosis] patients" and the researchers were able to replace the defective gene
and restore function).
45.
CRISPR/Cas9 for Hemophilia, HEMOPHILIA NEWS TODAY, https://hemophilia
newstoday.com/crispr-cas9-hemophilial (last visited Jan. 26, 2017) [https:/perma.cc/LUT7D4N2] (archived Jan. 26, 2017).
46.
Id.
47.
Id.
48.
Antonio Regalado, Engineeringthe Perfect Baby, TECH. REv. (Mar. 5, 2015),
https://www.technologyreview.com/s/535661/engineering-the-perfect-baby/ [https://perma.cc/
4Z95-N87G] (archived Jan. 26, 2017).
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scenarios that could catapult the world into an era that now seems
more appropriately confined to science fiction films. 49 Yet, while these
extreme scenarios should be considered and are reviewed in Part III,
the true dispute lies in what CRISPR-Cas9 currently is, or will shortly
be capable of. Some companies and researchers believe that this
technology will allow individuals to choose at least some traits of their
offspring. OvaScience, a Cambridge, Massachusetts-based company,
argues that this technology will allow parents to choose not only "when
and how they have children [but also] how healthy those children are
going to be." 50 David Sinclair, a geneticist at Harvard University and
co-founder of OvaScience, stated at a commercial presentation in
December 2016 that "there is no reason to expect" that the ability to
remove defective genes, referring to those in genetic diseases, "won't be
possible in coming years." 51
On the other hand, other members of the scientific community
believe that the idea of genetically engineering a "perfect" society is
nowhere close to being attainable. 52 Dr. Stuart Kim, a genetics
professor at Stanford, argued that the notion of making an individual
faster or more resilient is "still far enough off, [that it] might as well be
the stuff of science-fiction [sic] ."** Similarly, Rudolf Janeisch, a
biologist at the Massachusetts Institute of Technology, stated that any
"attempts to edit human embryos [are] 'totally premature.' 54 In fact,
in studies that use CRISPR-Cas9 editing in animal subjects,
researchers noted that the reality of obtaining an embryo with both
genes edited as desired is actually only a one in twenty chance.5 5
Further, researchers are only beginning to study the use of the
technology as a treatment for single-gene disorders, but many traits,
such as increasing resistance to muscular injury, involve multiple

49.
See Claire Brownell, From curing diseases to making designer babies, human
gene editing is coming, FIN. POST (July 22, 2016), http://business.financialpost.comI/executive/
smart-shiftfrom-curing-diseases-to-making-designer-babies-human-gene-editing-is-coming
[https://perma.cc/T3VJ-DNZ5] (archived Jan. 26, 2017) ("If CRISPR is used
irresponsibly, it's possible to imagine all sorts of extreme scenarios: parents creating
designer babies; Hitler-like figures wiping out entire races; the entire Jurassic Park
franchise coming to life.").
50.
Regalado, supra note 48.
51.
Id.
52.
See Erin Beresini, Could CRISPR Genetically Tailor Athletes? It's a Nice
Idea, OUTSIDE (Jan. 7, 2016), http://www.outsideonline.com/2045666/could-crisprgenetically-tailor-athletes [https://perma.cc/T3BS-FX3V] (archived Mar. 25, 2017)
(discussing the limitations of the gene-editing technology).
53.
Id.
54.
Regalado, supra note 48.
55.
Id. ("Only about half the embryos will lead to live -births, and of those that
do, many could contain a mixture of cells with edited DNA and without. If you add up
the odds, you find you'd need to edit 20 embryos to get a live monkey with the version
you want.").
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genes. 56 Before being able to genetically modify an individual with the
trait, scientists would need to determine how the genes interact.57
Nonetheless, this disagreement regarding the capabilities of
CRISPR-Cas9 in gene editing illustrates the uncertainty as to what
doors the Chinese research opened and what realms of genetic
modification are possible currently and in the future. Without proper
regulations and research, there are many technical and ethical issues
that the international community must address to avoid exploitationparticularly given the eugenics problems of the past.
III. HISTORICAL REVIEW OF PERFECTION THROUGH EUGENICS

Many in the scientific community, as well as speakers at the
National Academies' Summit, recommend that scientists take a more
cautious approach in implementing this technology, and some
explicitly believe that researchers should not pursue gene editing in
58
This reluctance for
human embryos, even for clinical practices.
allowing or facilitating changes in an individual's genetic traits can be
seen not only in modern ethical debates, but also throughout history.
As one scholar aptly noted
[w]e recognize ourselves, measured against such goals and ideals, to be imperfect
creatures. We wish to be more generous, more mathematically able, more
musical, more altruistic - less like brutes and more like gods. . . [y]et as noble as
our aspirations for shedding our failings might be, our history also suggests that,
being flawed as we are, we can never blindly trust our own aspirations to reshape
ourselves.59

It is the desire for this illusive perfection that has etched a path of
atrocities throughout history. As another speaker at the International
Summit stated, "not everything that is technically feasible is ethically
desirable."6 0 Although genetic modification through the gene editing of

See Beresini, supra note 52 ("[I]ncreasing resistance to muscular injury or
56.
stress fractures, for example, would likely involve multiple genes, and figuring out how
altering one might affect the behavior of others is a puzzle that could take decades to put
together.").
57.
See id. (noting that current research is mainly focused on single gene
disorders as opposed to those in which multiple genes interact).
See, e.g., John P. Holdren, Dir. White House Office of Sci. & Tech. Pol'y,
58.
Opening Remarks (Dec. 1, 2015), https://vimeo.com/album/3703972/video/149179773
[https://perma.cclYWJ2-A8E6] (archived Jan. 26, 2017) (presenting Holdren's belief that
using the CRISPR technology to modify the gene line should not be done even for clinical
practices while the technology still has many uncertainties).
CELESTE M. CONDIT, THE MEANINGS OF THE GENE: PUBLIC DEBATES ABOUT
59.
HUMAN HEREDITY 245 (1999).

Ismail Serageldin, The Librarian of Alexandria, Context Through Three
60.
Lenses: Scientific, Historical, Legal (Dec. 1, 2016) (https://vimeo.com/album/3703972/
video/149182559 [https://perma.cclA77G-3EWR] (archived Jan. 26, 2017).
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embryos is only in the beginning stages of development, society's
concerns stem in part from the horrors associated with human
experimentation in the past.
These concerns arise from certain historical periods including the
sterilization laws of the United States and the eugenics practices of the
Nazi party during the Holocaust-and these examples are neither the
earliest nor the only instances of society's drive towards perfection at
the cost of innocent life and human rights. In the Hellenistic period of
Ancient Greece, for instance, the goal to perfect male soldiers drove the
nation-state of Sparta to practice infanticide in order to eliminate those
perceived to be weak. 61 While these examples may differ from gene
editing on their face, they underlie the ethical apprehension that
modification to eliminate alleged flaws will go too far. Therefore,
scientists and legal ethicists should be cognizant of this past in
determining how to move forward.
A. Sterilization Laws in the United States
Due to the appalling scope of the atrocities attributed to the
Holocaust, many members of the American public may be unaware
that eugenic policies flourished in the early-twentieth century in the
United States. 62 At the turn of the twentieth century, most of the
American scientific and medical community hypothesized that
infirmities, such as "feeblemindedness, epilepsy, drunkenness,
criminality and insanity," were hereditary and passable to offspring. 63
Scientist believed that individuals with these conditions represented
the lowest social sphere in society, reflecting undesirable traits that
should be eliminated from the population. The movement gained
holding, and, by 1913, fourteen states had active involuntary
sterilization programs.64 However, every court faced with the issue of
whether these programs violated the Constitution invalidated the
laws-often on Due Process grounds.6 5
Nonetheless, sterilization laws resurged in the 1920s and
eventually a case regarding the forced sterilization of a mentally

61.
WALTER BERNS, MAKING PATRIOTS 12 (2001) ("[A]nd whose infants, if they
chanced to be puny or ill-formed, were exposed in a chasm (the Apothetae) and left to
die.").
62.
See generallyPHILIP R. REILLY, EUGENICS, ETHICS, STERILIZATION LAWS 204,
204-08, in 1 ENCYCLOPEDIA OF ETHICAL, LEGAL, AND POLICY ISSUES IN BIOTECHNOLOGY

(Thomas H. Murray & Mazwell J. Mehlman eds., 2000) (discussing the sterilization laws
of the United States and the rationales behind their enactment).
63.
Id.
64.
Id.
65.
See id. ("In every instance (Indiana, Iowa, Michigan, Nevada, New Jersey,
New York, and Washington) in which the constitutionality was put at issue, the courts
invalidated the laws, usually on the grounds that they violated the requirements of the
Due Process Clause of the Fourteenth Amendment.").
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handicapped individual, Carrie Buck, went to the United States
Supreme Court in 1927.66 The resulting case, Buck v. Bell, has been
called "the single most important event in the history of sterilization
laws in the United States."6 7 Justice Holmes' majority opinion held
that "in order to prevent our being swamped with incompetence. . . [i]t
is better for all the world, if instead of waiting to execute degenerate
offspring for crime, or to let them starve for their imbecility, society can
prevent those who are manifestly unfit from continuing their kind." 68
In reference to perceived disabilities of Buck's mother and one of Buck's
children, the opinion went on to astonishingly note that "[t]hree
generations of imbeciles are enough." 69 Although sterilization has
mostly fallen out of favor, largely due to the immense backlash
following the Holocaust-discussed in the next Section-states retain
the right to enforce sterilization laws.70 As of 2004, seven states still
had laws allowing for compulsory sterilization, and there are some
estimates that over sixty thousand Americans have undergone forced
sterilization.71 Even the Patient Protection and Affordable Care Act
72
included sterilization as a "preventive care" service.
B. The Nazi Regime and Hitler's Eugenic Movement
As the eugenics movement began to build more strength, the
United States' sterilization measures eventually made their way
overseas to Germany.7 3 Henry Hamilton Laughlin, a major eugenics
advocate and director of the Eugenic Records Office, had developed
sterilization laws that bypassed due process concerns. 74 When his work

See id. (discussing the resurgence of sterilization laws in 1923 and the
66.
infamous Supreme Court case of Buck v. Bell).
Id.
67.
Buck v. Bell, 273 U.S. 200, 207 (1927). Buck v. Bell has never explicitly been
68.
overturned.

Id.
69.
70.
See Ariel S. Tazkargy, From Coercion to Coercion: Voluntary Sterilization
Policiesin the United States, 32 LAw & INEQ. 135, 135 (2014) ("Physicians, in the absence
of state laws that mandate otherwise, still retain unfettered authority to prescribe or
refuse sterilization procedures.").
Michael G. Silver, Note, Eugenics and Compulsory Sterilization Laws:
71.
ProvidingRedress for the Victims of a Shameful Era in United States History, 72 GEO.
WASH. L. REV. 862, 863 (2004) (discussing the impact and current status of sterilization
laws in the United States).
Tazkargy, supranote 70, at 135.
72.
See REILLY, supranote 62 (noting that the model sterilization laws of Henry
73.
Laughlin "found their way to Nazi Germany" where he was held in "high regard").
Henry Laughlin, originally a high school teacher and highly respected
74.
biologist, provided "scientific legitimacy" to eugenics and analyzed laws to draft model
laws that would not suffer the same constitutional invalidity of the sterilization laws of
the 1910s. See id.
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reached Nazi Germany, it was so well regarded that the University of
Heidelberg awarded Laughlin an honorary degree in 1934.71
Throughout the Holocaust and Hitler's overt goal to proliferate a
superior race, the Nazi regime deemed millions of European Jews
along with many Russians, Gypsies (Romani), Poles, and disabled
individuals, undesirable.7 6 Nazi-regime physicians participated in
programs that involved coercive sterilization, harmful and barbaric
experimentation, and the killing of impaired children and allegedly
defective adults from mental hospitals, institutions, and concentration
camps such as Auschwitz.7 7
Physicians conducted these experiments, according to the Nazis,
"for 'the advancement of science."' 7 8 The experimentations included
sterilization, "exposure to low temperature and atmospheric pressure,"
and "deliberate wounding with infection to test antibiotics."7 9 The Nazi
regime considered the extermination of the Jewish population a
"program of racial hygiene" premised on the belief that a non-Aryan
race created "a public health threat," and, therefore, elimination "was
medically akin to excising a dangerous tumor."80 Gideon Hausner, the
chief prosecutor at the 1961 trial of Nazi war criminal Adolf Eichmann,
stated that "[tihe Nazis regarded Auschwitz as the ideal place for
experimentation, for the creation of supermen."8 1 One statistic notes
that "over 400,000 Germans had been sterilized including 200,000
deemed mentally deficient; 100,000 with mental illness; 60,000
epileptics; 10,000 alcoholics; 20,000 with body deformities; and others
afflicted with Huntington's chorea, hereditary blindness or
deafness." 82 The Nazi Regime also ordered the killings of numerous
infants born with deformities or brain damage.8 3

75.

Id.

76.

See, e.g., JOSHUA

A. PERPER & STEPHEN J. CINA, WHEN DOCTORS KILL: WHO,

WHY, AND HOW 61 (2010) (discussing the populations affected by the eugenics movement
in Germany during the Holocaust).
77.
See id. at 58 ("Nazi physicians also participated in other progressively
injurious or murderous programs including coercive sterilization, the killing of 'impaired'
children in hospitals, and the eradication of 'defective' adults mostly from mental
hospitals or institutions in special centers.").
78.
Id.
79.
See Howard Brody, The Originsand Impact of the NurembergDoctors' Trial,
&

in HUMAN SUBJECTS RESEARCH AFrER THE HOLOCAUST 163-64 (Sheldon Rubenfeld

Susan Benedict eds., 2014) (providing an overview of the different types of
experimentations individuals were subjected to under the Nazi regime).
Id. at 164.
80.
81.
Jonathan Broder, Auschwitz Survivors Recall Horror of Nazi Experiments,
CHI. TRIB. (Feb. 7, 1985), http://articles.chicagotribune.com/1985-02-07/news/8501080137
1ljosef-mengele-israel-and-west-germany-auschwitz [https://perma.cc/LWB3-AV9G]
(archived Jan. 27, 2017).
82.
PERPER & CINA, supra note 76, at 58.
83.
See id. ("In the end, 70,000 German children thought to be abnormal were
forcefully taken from their homes, institutionalized, and eventually killed.").
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This rapid and extreme escalation from sterilization to genocide
sparked outrage, discrediting and shaming eugenics; 84 but, many of
those involved in the Nazi movement, including physicians, believed
they were promoting science.8 5 Their claimed goal was improving the
human race by manipulating genetic traits-discouraging and
eliminating negative traits, known as negative eugenics, and
86
promoting positive and desirable traits, known as positive eugenics.

While dissimilar in how they obtain this goal, clinicians use a
version of genetic manipulation in pre-natal testing and screening, and
in genetic counseling.87 Against this historical backdrop, many in the
scientific and medical communities worry that the current
advancements in gene editing could eventually overstep the ethical
limits of science.8 8 One example of such an inappropriate use would be
the proliferation of designer babies.89
IV. THE CURRENT STATE OF LAWS: THE UNITED STATES, THE UNITED
KINGDOM, AND THE PEOPLE'S REPUBLIC OF CHINA

The capabilities of CRISPR-Cas9 described in Part II, along with
the historical concerns reviewed in Part III, enforce the belief that,
despite any uncertainty as to the full extent of the technology's
capabilities, the time for a global discussion on ethical limitations is
now. As noted previously, three players are at the forefront of gene
editing: the United States, the United Kingdom, and China. In order
to devise a recommendation for regulating gene editing, this Note
analyzes the current laws and regulations in place in these countries.
Arguably, this subject would benefit from a review of the laws of
additional countries in formulating a proposed solution, but such an
endeavor is beyond the scope of this Note. Because these three
countries co-hosted the International Summit and they are making the

See Ana Romero-Bosch, Lessons in Legal History-Eugenics & Genetics, 11
84.
MICH. ST. J. MED. & L. 89, 99-100 (2007) ("Nazi racial hygiene programs radically
changed from controlling reproduction and marriage to the massive murder and gassing
of thousands of innocent people. . . . Ultimately, the Holocaust served to discredit and
shame eugenics practitioners worldwide.").
See PERPER & CINA, supra note 76, at 62 (providing an overview for the
85.
argued medical justifications for the experimentation).
See id. at 59 (discussing the reason behind physician involvement in the
86.
mass killings and experimentations).
See id. at 62 (noting that "in modern times, [eugenics] has played a formative
87.
role in pre-natal testing and screening, genetic counseling and molecular correction of
genetic diseases").
See Mike Steere, Designer Babies: Creatingthe Perfect Child, CNN (Oct. 30,
88.
http://www.cnn.com/2008/TECH/science/10/30/designer.babies/
10:38
AM),
2008,
[https://perma.cc/SY8F-7SDX] (archived Jan. 27, 2017) (questioning whether the idea of
designing your child is a "scary thought").
See id. (describing the concept behind designer babies).
89.
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most leeway in research, it is likely that other countries will look to
their actions in deciding how to regulate gene editing domestically.
A. The United States

'

Shortly after the news spread of the Chinese researchers' geneediting experiments, the National Institutes of Health (NIH) issued a
statement that it would "not fund any use of gene-editing technologies
in human embryos." 90 The NIH proclaimed that not only is the use of
this technology "a line that should not be crossed," but also that "there
are multiple existing legislative and regulatory prohibitions" which
prohibit such work. 9
One such regulatory barrier to gene editing of human embryos is
the Dickey-Wicker amendment.9 2 The amendment prohibits the
Department of Health and Human Services (HHS) from using any
appropriated funds for both "the creation of a human embryo or
embryos for research purposes" and "research in which human
embryos are destroyed, discarded, or knowingly subjected to risk of
injury or death greater than that allowed for research on fetuses in
utero" 9 according to applicable federal law. 94 Pursuant to this
legislation, the most recent NIH guidelines state that "[t]he NIH
continues to explore the issues raised by the potential of in utero gene
transfer clinical research. However, the NIH concludes that, at
present, it is premature to undertake any in utero gene transfer clinical

90.

Statement on NIH funding of research using gene-editing technologies in

human embryos U.S. DEP'T OF HEALTH & HUMAN SERVS., NAT. INSTS. OF HEALTH,

(2015), http://www.nih.gov/about-nih/who-we-are/nih-director/statements/statement-nihfunding-research-using-gene-editing-technologies-human-embryos [https://perma.cclLT9MBNMF] (archived Jan. 28, 2017).
91.
See id. (discussing the prohibitions within a variety of legislative and
regulatory materials including the Dickey-Wicker amendment, NIH guidelines, and the
authority of the Food and Drug Administration).
92.
The Balanced Budget Downpayment Act, Pub. L. No. 104-99, § 128, 110 Stat.
26 (1996).
Id.
93.
94.
In March 2009, President Obama issued an executive order removing this
restriction for the purposes of stem cell research if the research did not destroy the stem
cells and researchers did not create stem cell lines. See Exec. Order No. 13,505, 74 F.R.
10667 (2009); see also Sherley v. Sebelius, 680 F.3d 776 (D.C. Cir. 2012) (holding that
the NIH guidelines in response to Executive Order 13505 remained in line with the
Dickey-Wicker Amendment as they only permitted the use of already-derived embryonic
stem cells, which are not themselves embryos, and thus no embryos would be destroyed).
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trial."9 5 Still, there is some suggestion that the United States may be
moving towards eliminating some of these restrictions."
The organizational structure for regulating gene editing, which
does not relate to the banned research on human embryos, is multifaceted. The NIH's Recombinant DNA Advisory Committee (RAG)
determines whether to approve gene-editing proposals that seek
government funding.9 7 Recently, the RAC approved "the first clinical
protocol to use CRISPR/Cas9-mediated gene editing"98 in an effort to
treat multiple kinds of cancer.99 The second key federal player in the
gene-editing realm is the Food and Drug Administration (FDA), whose
"Center for Biologics Evaluation and Research (CBER) has a wellestablished program and policies in place to evaluate gene therapy
products." 0 0
Despite this seemingly thorough federal structure, David Magnus,
the Director of the Stanford Center for Biomedical Ethics, and Nicole
Martinez, a lecturer and fellow at Stanford University, have criticized
the United States regulatory control of gene editing "as a 'wild west' of
reproductive technology."1 0 Although HHS and the NIH limit what

95.

NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic

Acid Molecules, U.S. DEP'T OF HEALTH AND HUMAN SERVS., NAT. INSTS. OF HEALTH,

(2016), http://osp.od.nih.gov/sites/default/files/NIH_Guidelines.html [https://perma.cc/
QBN4-EEXL] (archived Jan. 28, 2017) (emphasis in original).
96.
See Zachary Brennan, CongressionalHearings Focus on CompassionateUse,
FDA Issues, REG. AFFAIRS PROF'LS SOc'Y (Feb. 25, 2016), http://www.raps.org/RegulatoryFocus/News/2016/02/25/2441O/Congressional-Hearings-Focus-on-Compassionate-UseFDA-Issues/ [https://perma.cc4RBS-759F] (archived Jan. 28, 2017) (noting that some
members of Congress question the extent of U.S. restrictions on genetic modification of
human embryos including Representative Sam Farr of California who said that the
provision was aimed "to stop designer babies though he thought that the actual language
of it went too far and would mean the US will lose research opportunities") (internal
quotations omitted).
Robert M. Califf & Ritu Nalubola, FDA's Science-based Approach to Genome
97.
Edited Products, U.S. FOOD & DRUG ADMINISTRATION, DEP'T OF HEALTH & HUM. SERVS.

(Jan. 18, 2017), http://blogs.fda.gov/fdavoicelindex.php/2017/01/fdas-Science-basedapproach-to-genome-edited-products/ [https://perma.cc/2NGT-SR6J] (archived Jan. 28,
2017).
Id.
98.
Sharon Begley, Federalpanel approves first use of CRISPR in humans, STAT
99.
(June 21, 2016), https://www.statnews.com/2016/06/21/crispr-human-trials/ [https:/Iperma.
cc/PB72-V5EJ] (archived Jan. 28, 2017) ("A federal biosafety and ethics panel on
Tuesday unanimously approved the first study in patients of the genome-editing
technology CRISPR-Cas9, in an experiment that would use [CRISPR] to create
genetically altered immune cells to attack three kinds of cancer.").
100.
Califf & Nalubola, supra note 97.
See David Magnus & Nicole Martinez, In Embryo Research We Need Laws
101.
First, Then Science, TIME (Feb. 2, 2016), http://time.com/4204059/crispr-regulation/
[https://perma.cc/Z6A4-RK2C] (archived Jan. 28, 2017) (discussing the inefficiencies of
embryonic research regulations in the United States, particularly in reference to the
United Kingdom and China).
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research may receive funding, there is no government agency or
authority that regulates privately funded projects. 102 Therefore, unlike
the United Kingdom (discussed in the subsequent Section), it is not
illegal in the United States to implant a genetically modified embryo
to begin a pregnancy.10 3 Further, based on the vital Separation of
Powers Doctrine in the United States, some states are looking to their
laws and guidelines to see if it is permissible to fund research on the
gene editing of human embryos. 104 The California Institute for
Regenerative Medicine is considering whether to fund such an
endeavor, and it would do so with California taxpayer dollars. 05 Such
a gap in regulations between federal and state researchers illustrates
the worrisome inefficiencies in the current U.S. gene-editing
regulatory scheme.
B. The United Kingdom
Discussions of reproductive medicine have often focused on the
United Kingdom, perhaps more so than any other region in the
world.1 06 England was the first country to have a test-tube baby, to use
pre-implantation genetic diagnostics, and to clone a higher
vertebrate.1 0 7 It also has been a leader "in human embryonic stem cell
derivation and banking." 0 8 These many achievements influenced the
United Kingdom's "creation of rigorous legislation and policy strictly
limiting [the] technological manipulation of human fertilisation and
embryology." 09 This legislation and policy allows the United Kingdom
to have "a uniquely-robust-but-flexible" approach to embryological

102.
See id. ("In contrast, privately funded gene-editing projects are not regulated
by a central agency or framework that can address concerns of safety and efficacy, or
balance the interests of research with the protection of patients.").
103.
See Melody Peterson, Californiastem cell agency may fund tests to edit genes
in human embryos, L.A. TIMES (Feb. 12, 2016, 3:00 AM), http://www.latimes.com/business/
la-fi-human-gene-editing-20160212-story.html [https://perma.cc/RU5N-KCSG] (archived
Jan. 28, 2017) (noting the differences in the acceptability of embryonic genetic
modification in the legal standards of the United States and the United Kingdom,
specifically Britain).
104.
See id. (discussing California's investigation into whether its ethical
guidelines allow its agencies to use taxpayer funds to support research regarding
genetically modifying human embryos).
105.
See id. ("The state's stem cell institute is reviewing its ethics guidelines to
determine whether they are strong enough to safely allow studies in which scientists
would attempt to edit the genes of embryos.").
106.
See SARAH FRANKLIN & CELIA ROBERTS, BORN AND MADE: AN ETHNOGRAPHY
OF PREIMPLANTATION GENETIC DIAGNOSIS 2 (2006) ("Britain has in many respects been

at both the center and forefront of the controversies surrounding a cluster of new
technologies associated with reproductive biomedicine.").
107.
Id.
108.
See id. (discussing all the "firsts" in reproductive medicine that Britain
accomplished) (internal quotations omitted).
109.
Id. (internal quotations omitted).
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testing, with the enforcement of criminal law, the presence of a
licensing body, and the allowance for revisions in the legislation by
Parliament. 110
The Human Fertilisation and Embryology Act ("The Act") governs
the Human Fertilisation & Embryology Authority (HFEA), which
regulates all research involving human embryos in the United
Kingdom.' The Act imposes strict limitations, including an outright
ban on the use of modified embryos for pregnancy, stating that the Act
only permits implantation of an embryo if "no nuclear or mitochondrial
DNA of any cell of the embryos has been altered and no cell has been
112
The
added to it other than by division of the embryo's own cells."
regulations noticeably do provide a possible exception if researchers
process the embryo "to prevent the transmission of serious
mitochondrial disease."" 3 Additionally, researchers may apply for
licenses if they are able to meet strict requirements including
educational standards, two years practical experience related to the
114
activity, and payment of a fee.
Parliament recently amended the Act in 2008 to address some of
the evolving aspects of genetic research. The explanatory notes discuss
the changing of definitions such as "embryo," which Parliament
modified to "no longer assume[] that an embryo can only be created by
fertilisation" and to bring the definition "up to date with technologies
that have been developed since the time of enactment of the 1990
Act.""15 The notes further acknowledge that the limitation on
implantation "ensures embryos created by artificial gametes or
1 16
The
genetically modified gametes could not be placed in a woman."
previous 1990 Act strictly prohibited alteration of the genetic structure
of an embryo unless Parliament enacted specific regulations; however,
7
The removal of this
Parliament made no such regulations.11

110.
See id. at 3 (noting that Britain's system is "backed up by criminal law,
enforced through a licensing body, and subject to constant revision, while being bound
by the 'will of Parliament').
111.
Human embryo research,HUMAN FERTILISATION & EMBRYOLOGY AUTHORITY
(UK), http://www.hfea.gov.uk/161.html (last visited Feb. 20, 2017) [https://perma.cc/BLX42L2Y] (archived Jan. 29, 2017).
Human Fertilisation and Embryology Act 2008, 2008 c. 22, §3(5)(4)(b-c) (UK).
112.
Id. at §3(5)(5).
113.
Id. at §16.
114.
Human Fertilisation and Embryology Act 2008, c.22, Explanatory Notes 1
115.
23 [hereinafter Explanatory Notes].
Id. 1 29.
116.
Id. ¶ 65 (discussing previous paragraph 3(4) of Schedule 2 to the 1990 Act
117.
and its prohibitory language).
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prohibition paved the way for the licensure requirements to now
govern embryonic modification research.11 8
London researchers used this licensing scheme recently to gain
permission to genetically edit human embryos.1 19 A couple donated the
embryos, which doctors or researchers could never legally implant per
regulations, from their surplus after IVF treatment. 120 The HFEA
granted the license on February 1, 2016.121 The research license allows
for the keeping, use, and storage of embryos for a period of three years,
with the option of renewal.1 22 The license notes that these activities
are for the purpose of "developing treatments for serious disease or
other serious medical conditions," "increasing knowledge about the
development of embryos," and "promoting advances in the treatment
of infertility."1 23 Nonetheless, the HFEA committee reiterated the
prohibition that the research project can never involve placing nonpermitted embryos, eggs, or sperm in a woman, or keeping or using
embryos after fourteen days from the date of creation or upon the
appearance of a primitive streak 24. 12 5 Additionally, no research using
gene editing can take place until the research receives an ethics
approval. 126 Although China was the first to use CRISPR-Cas9 for
gene-editing purposes, this licensure approval represents the first
endorsement worldwide of research of this kind by a national
regulatory authority, and many scholars believe that it has established
a strong precedent for this type of research.1 27

118.
See id. (discussing the removal of prohibitions on all genetic modification
absent regulations and instead allowing for HFEA approved licensure).
119.
See Ewen Callaway, UK scientists gain license to edit genes in human
embryos, NATURE (Feb. 1, 2016), http://www.nature.com/news/uk-scientists-gain-licenceto-edit-genes-in-human-embryos-1.19270 [https://perma.cc/JQ4B-GFDG] (archived Jan.
29, 2017) (discussing the HFEA's approval of the Francis Crick Institutes license
request).
120.
See Jan Sample, UK scientists seek permission to genetically modify human
embryos, GUARDIAN (Sept. 17, 2015, 7:01 PM), http://www.theguardian.com/science/2015/
sep/18/uk-scientists-seek-permission-to-genetically-modify-human-embryos [https://
perma.cc/MRD6-TLDM] (archived Jan. 29, 2017).
Callaway, supra note 119.
121.
HUMAN FERTILISATION & EMBRYOLOGY AUTHORITY, LICENSE COMMITTEE

-

122.

MINUTES (Jan. 14, 2016), http://guide.hfea.gov.uk/guide/ShowPDF.aspx?ID=5966 [https://
perma.ccl6CTQ-BECZ] (archived Jan. 29, 2017) [hereinafter License Committee].
123.
Id.
124.
A primitive streak is a structure that arises during embryologic development
that is considered the beginning of the neural tube and nervous system. PrimitiveStreak,
MERRIAM-WEBSTER ONLINE DICTIONARY (2016), http://www.merriam-webster.com/

dictionary/primitive%20streak [https://perma.cc/U6B2-U8EK] (archived Mar. 25, 2017).
125.
License Committee, supra note 122.
126.
Id.
127.
See Callaway, supra note 119 (discussing the international impact of the
HFEA's approval of the research).
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C. The People's Republic of China
Like the United Kingdom, China theoretically has an outright
legislative ban on gene editing of human embryos.' 2 8 Yet despite this
legislation, commentators have referred to China's stem cell treatment
and research as "wild" 129 as China has "one of the most unrestrictive
regulatory regimes ... ."130 Despite enacted regulations, no real legal
enforcement mechanism exists and loopholes in the guidelines are
widespread.1 3 1 It is through one of these loopholes-the researchers'
use of non-viable embryos that could never be implanted-that the
Chinese researchers were able to become the first country in the world
to edit the genes of a human embryo. 132
Similar to the United Kingdom, researchers cannot develop
embryos past fourteen days, and the government strictly prohibits the
implantation of modified embryos into humans.' 3 3 The only ethical
guidelines for regulating this type of research arise from a 2003 joint
issuance from the Ministry of Science and Technology and the Ministry
of Health, The Guidelines for Ethical Principlesin Human Embryonic
Stem Cell Research.134 These guidelines permit the use of embryonic
stem cells in research from specified sources such as unwanted
embryos from IVF, miscarriages, and voluntarily induced abortions, as
well as donated germ cells.13 5 Still, the guidelines dictate a complete
ban on "[u] sing human egg plasma and nuclear transfer technology for
the purposes of reproduction, and [the] manipulation of the genes in
human gametes, zygotes or embryos for the purposes of reproduction
are prohibited."1 36

128.
See Skye Gould & Kevin Loria, This map shows where researchers might
design the first genetically engineered baby, BUS. INSIDER (Oct. 20, 2015, 12:48 PM),
http://www.businessinsider.com/what-countries-allow-researchers-to-edit-human-embryos2015-10 [https://perma.cc/UPY5-DNRC] (archived Jan. 29, 2017) (providing an overview
of foreign law regulations on genetic modification).
129.
Shan Juan, Health authority announces step to rein in 'wild' stem cell
treatment, CHINA DAILY (Aug. 21, 2015), http://www.chinadaily.com.cn/china/201508/21/content_21662613.htm [https://perma.cclDJL7-RLJA] (archived Jan. 29, 2017)
(discussing changes made by the Chinese Health authority to stem cell treatments and
experimentation).
Laney Zhang, Bioethics Legislation in Selected Countries, LAW LIBRARY OF
130.
CONG. (2012), https://www.loc.gov/law/help/bioethics-2012-008118FINAL.pdf [https://
perma.cclHNY3-7QF4] (archived Jan. 29, 2017) [hereinafter Bioethics Legislation].
131.
See Gould & Loria, supra note 128.
132.
See id.
133.
Bioethics Legislation, supra note 130.
Id.
134.
Id.
135.
Zihong Xu, Professor, Peking University & Chinese Academy of Sciences,
136.
PowerPoint Presentation at the International Summit on Gene Editing: Human Embryos
and Gene-Editing Research and Regulation in China (http://www.nationalacademies.
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Other agencies involved, or potentially involved, in regulating
gene editing in China include the National Health and Family
Planning Commission (NHFPC) and the Chinese Food and Drug
Administration (CFDA). The NHFPC is charged with the guidance and
formation of scientific programs related to health and family
planning.1 3 7 The CFDA regulates genetic testing and had previously
banned prenatal DNA testing in 2014.138 However, the ban allowed
clinical applications of gene sequencing to continue if they were
approved by the NHFPC and were done according to regulations.1 39
Given the country's restrictive guidelines prohibiting gene editing for
the purpose of reproduction, much speculation arose as to how the
Chinese research team was able to conduct this research
experiment.14 0 Two theories have emerged.141 First, the researchers
used non-viable embryos-those unable to develop into humans
because they were fertilized by two sperm.1 42 Second, China's
regulatory bans actually "consist mostly of guidelines," which are
considered "soft laws," leaving sanctions ambiguous and possibly
unenforceable. 143

org/cs/groups/genesite/documents/webpage/gene_169524.pptx [https://perma.cc/ZN8RGVFZ] (archived Jan. 29, 2017)).
137.

About Us, NAT'L HEALTH AND FAMILY PLANNING COMM'N OF THE PRC,

http://en.nhfpc.gov.cni/pohcies_2.html (last visited Jan. 29, 2017) [https://perma.cc/AZM4AYPY] (archived Jan. 29, 2017).
138.
See Sophie Hohn, China Imposes Restrictive Regulation of Genetic Testing,
INT'L RARE DISEASES RESEARCH CONSORTIUM (Apr. 1, 2014), http://www.irdirc.org/china-

imposes-restrictive-regulation-of-genetic-testing/ [https://perma.ccl69GA-HFG3] (archived
Jan. 29, 2017) (discussing the CFDA's regulatory constraints on clinical genetic tests).
139.
See Shu-Ching Jean Chen, China Cracks Down on DNA Testing, FORBES
(Mar. 3, 2014, 10:06 AM), http://www.forbes.com/sites/shuchingjeanchen/2014/03/03/chinacracks-down-on-dna-testing-2/ [https://perma.cc/BL2W-YVV7] (archived Jan. 29, 2017)
("From now on, clinical applications of gene-sequencing technology can be offered only at
locations approved as pilot trial points by the National Health and Planning
Commission ... [a]nd they have to be done according to regulations.").
140.
See Lauren F. Friedman, These are the countries where it's 'legal' to edit
human embryos (hint: the US is one), BUS. INSIDER (Apr. 23, 2015, 2:15 PM), http://www.
businessinsider.com/china-edited-human-genome-laws-2015-4 [https://perma.cc/X2ZFXPAB] (archived Jan. 29, 2017) (commenting on the debate as to whether the Chinese
research was allowed).
141.
Id.
142.
Id.
143.
Id.
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V. THE NATIONAL ACADEMIES' SUMMIT AND REPORT

A. The InternationalSummit Recommendation
After reviewing the individual policies of these three nations, it
would be amiss not to evaluate the recommendations put forth after
the International Summit on gene editing. The International Summit
consisted of several days of discussions, debates, and even appeals from
the general public affected by genetic disorders. Approximately five
hundred "scientists, ethicists, legal experts and advocacy groups"
represented more than twenty countries. 144 The summit addressed
multiple topics at length: the scientific, historical, and legal context;
the scientific background of gene editing technologies; the application
of gene editing technology to change the genetic makeup of offspring;
the societal impacts; the limitations; the application of gene editing
technology to research; governance, regulation, and control; and
14 5
international perspectives.
After several presentations and panel discussions over the threeday event, it became apparent that there was a disagreement as to the
scope of the technology's potential for genetic editing and modification.
Despite this disagreement on certain topics, a common theme of
caution and ethical concern emerged. The committee addressed the
different uses of the CRISPR-Cas9 gene-editing technology in their
closing recommendations. 146 The organizing committee, comprised of
twelve biologists and bioethicists, endorsed the use of CRISPR-Cas9 to
alter "DNA sequences of human eggs, sperm, or embryos" but did not
recommend the implantation of embryos through in vitro fertilization
147
"because of ongoing safety concerns and a lack of societal consensus."
In addition to the committee's general recommendation, the
committee first addressed the need for "intensive basic and preclinical
research" that should be conducted according to all the applicable legal,

Sara Reardon, Global summit reveals divergent views on human gene editing,
144.
NATURE (Dec. 8, 2015), http://www.nature.com/news/global-summit-reveals-divergentviews-on-human-gene-editing-1.18971 [https://perma.cc/8TWU-ZVNU] (archived Jan.
29, 2017).
Summit Draft Agenda, NAT'L ACADS. OF SclS, ENG'G, & MED., http://
145.
nationalacademies.org/cs/groups/genesite/documents/webpage/gene_168809.pdf (last
visited Jan. 29, 2017) [https:/perma.cc/32QX-HFTX] (archived Jan. 29, 2017).
David Baltimore, California Inst. of Tech., Going Forward: Closing Thoughts
146.
(Dec. 3, 2015) (unpublished presentation), http://nationalacademies.org/cs/groups/genesite/
documents/webpage/gene_169560.pptx [https://perma.cc/5RFL-H9UM] (archived Jan.
29, 2017) [hereinafter Closing Presentation].
See John Travis, Inside the Summit on Human Gene Editing: A Reporter's
147.
Notebook, Sci. MAG. (Dec. 4, 2015, 3:45 PM), http://www.sciencemag.org/news/2015/12/
inside-summit-human-gene-editing-reporter-s-notebook [https://perma.cc/G476-2H72]
(Jan. 29, 2017) (providing a brief overview of the International Summit's conclusions).
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ethical, and regulatory rules. 148 The research should address the
technologies for gene editing, "potential benefits and risks of proposed
clinical uses," and a further biological understanding of human
embryos and germ lines.1 49 However, the committee recommended
that any cells modified through gene editing should not be used for
implantation "to establish a pregnancy." 5 0 Second, the committee
discussed somatic clinical use. Somatic cells are those that cannot be
transmitted through progeny.1 5 Regardless of the cells' inability to
have a hereditary effect, the committee noted that there is a risk of
inaccurate editing 5 2 but recognized that the "existing and evolving
regulatory frameworks for gene therapy" allow regulators to determine
whether to approve clinical trials and therapies.1 53
. Most important to the ethical debate is the committee's third
recommendation. The committee recognized that it would be
"irresponsible" to continue with clinical uses of germline editing absent
further research and consideration.1 54 It discussed the need for
gathering additional information on the safety and efficacy of the
technology, particularly in relation to the "risks, potential benefits, and
alternatives."15 5 The committee also referenced the need to wait until
"there is broad societal consensus about the appropriateness of the
proposed application."1 56 Additionally, it proposed that clinical uses
should be utilized only when conducted "under appropriate regulatory
oversight."' 5 7 While the committee noted that none of those criteria
were presently met, they recognized that it may change over time:
Moreover, any clinical use should proceed only under appropriate regulatory
oversight. At present, these criteria have not been met for any proposed clinical
use: the safety issues have not yet been adequately explored; the cases of most
compelling benefit are limited; and many nations have legislative or regulatory
bans on germline modification. However, as scientific knowledge advances and
societal views evolve, the clinical use of germline editing should be revisited on
a regular basis.158

In the last line of this statement, the committee kept the door open
for possible future use of germline editing and did not mention how to
address the variance in laws among the international community.

148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.

Closing Presentation, supranote 146.
Id.
Id.
Id.
Id.
Id.
Id.
Id.
Id.
Id.
Id.
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B. The Consensus Report
The International Study released its consensus study report,
Human Genome Editing: Science, Ethics, and Governance, in February
of 2017. The report "permit[s] clinical research trials [using gene
editing] only for the compelling purposes of treating or preventing
serious disease or disabilities, and only if there is a stringent oversight
system able to limit uses to specified criteria."15 9 However, the report
notes that "[m]ore research is needed before any germline intervention
could meet the risk/benefit'standard for authorizing clinical trials" but
maintains that "caution does not mean that [such trials] must be
prohibited."160 Figure 1 below represents the report's recommendation
and the suggestions for regulatory oversight.
RECOMMENDATION 5-1. Clinical trials using heritable germline genome
editing should be permitted only within a robust and effective regulatory
framework that encompasses
* the absence of reasonable alternatives;
* restriction to preventing a serious disease or condition;
* restriction to editing genes that have been convincingly demonstrated
to cause or to strongly predispose to that disease or condition;
* restriction to converting such genes to versions that are prevalent in
the population and are known to be associated with ordinary health
with little or no evidence of adverse effects;
* the availability of credible pre-clinical and/or clinical data on risks and
potential health benefits of the procedures;
* during the trial, ongoing, rigorous oversight of the effects of the
procedure on the health and safety of the research participants;
* comprehensive plans for long-term, multigenerational follow-up that
still respect personal autonomy;
* maximum transparency consistent with patient privacy;
* continued reassessment of both health and societal benefits and risks,
with broad on-going participation and input by the public; and
* reliable oversight mechanisms to prevent extension to uses other than
preventing a serious disease or condition.
'

Figure 1: Human Genome Editing Report Recommendation1 6

159.
Summary of Recommendations, Human Genome Editing: Science, Ethics,
and Governance, NAT'L ACADs. OF SCIS. AND NAT'L AcAD. OF MEDICINE, http://
nationalacademies.org/cs/groups/genesite/documents/webpage/gene_177259.pdf (last
visited Feb. 19, 2017) [https://perma.cc/N298-4ZP8] (archived Feb. 19, 2017).
160.
THE NATIONAL ACADEMIES, HuMAN GENOME EDITING: SCIENCE, ETHICS, AND
GOVERNANCE 102 (2017).
161.
Id. 102-03
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While the report represents a pro-gene-editing stance for the
prevention of a serious disease or condition, it is less favorable for
possible enhancements of human genome. The report puts forth two
recommendations: (1) that clinical trials for such enhancement
purposes "should not at this time" be authorized by regulatory
agencies; and (2) that "[g]overnment bodies should encourage public
discussion and policy debate regarding governance of somatic human
genome editing for purposes other than treatment or prevention of
disease or disability." 162
This summarization is merely a simplistic representation of an
extremely complex, thorough, and well-reasoned report. Consequently,
an in-depth analysis of the report and its recommendations is beyond
the scope of this Note. This Note, instead, makes one critical claim in
response to, and disagreement with, the report: the report's use of "at
this time" in the first recommendation. The prohibition on
enhancement treatments is ill advised as it adds further ambiguity to
an already contentious topic. As Part III discussed, enhancement often
leads to the belief that some individuals are superior while others are
inferior. While, this may not result in a Gattaca-like situation, 163
history evidences that the threat of misuse is not a path that society
should take lightly. 164 Therefore, properly addressing this concern
requires explicit language prohibiting gene-editing technology for the
purpose of enhancement, which Part VI details.
VI. REFORMING LAws DOMESTICALLY AND INTERNATIONALLY

The world of genetic modification has the potential to develop
rapidly,1 65 and currently both the domestic and international fronts
display serious ambiguities. In order to address these issues, this Note
proposes a two-step solution. First, the gaps between private versus
public and state versus federal regulations on genetic modification in
the United States should be closed.1 66 To best correct these faults, the
United States should use its constitutional authority to create a federal

162.
Id. at 123.
GATTACA, supra note 1.
163.
164.
See supra Part III.
165.
See John Farrell, How Brave New World Is Sneaking Up On Us, FORBES
(Feb. 28, 2016, 9:33 AM), http://www.forbes.com/sites/johnfarrell/2016/02/28/how-bravenew-world-is-sneaking-up-on-us/#1a839d841700 [https://perma.cc/X3YJ-25R6] (archived
Jan. 29, 2017):
[G]iven the speed with which genomes can be sequenced and the massive amount
of personal genomic Big Data this will represent, it may not be long before the
deep interconnections between sequences are indeed well enough understood to
embolden scientists and prospective parents to attempt direct modification of
gene sequences for purely optional design changes in their offspring.
166.

See infra Section IV.A.
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law that mirrors that of the United Kingdom, with the National
Institutes of Health (NIH) handling the licensing.16 7 Second, in order
to strengthen the recommendations of the Academies and create an
international consensus, the Declaration on the Human Genome and
Human Rights should be revised to reflect a prohibition of gene editing,
at least until the technology and ethical implications can be better
understood.
A. Establishinga Licensing System in the United States
The United States prohibition of funding embryonic genetic
modification traces back to a provision placed into an appropriation bill
68
in 1993, and the legislature has renewed it every year thereafter.1
However, given the advances in science and the successes of the
international research community, this stance no longer seems
appropriate. As previously discussed, the United States has good
reason to be cautious. The government and courts upheld an era of
sterilization justified by the noble aim of the betterment of society. 169
Nonetheless, these concerns should not "entail wholesale rejection of a
technology that can teach us a great deal about how living creatures
develop and how cells specialize and function."17 0 Rather, Congress
should pass legislation allowing the research to go forward, with
several restrictions.
Under its Commerce Clause power, Congress can arguably
regulate both private and public research of genetic modification, as
both involve interstate commerce. 1 7' As CRISPR-Cas9 research
develops, donsumers may seek out the technology to genetically modify

167.
Although not discussed in this Note due to the complexity of the issue,
establishing a federal law in the United States is of particular importance. In Medellin
v. Texas, 552 U.S. 491, 504-05 (2008), the Supreme Court held that "not all international
law obligations automatically constitute binding federal law enforceable in United States
Court."
See Farrell, supra note 165.
168.
See supra Section III.A.
169.
Stephen Latham, Proceed With Caution, U.S. NEWS & WORLD REPORT (Feb.
170.
8, 2016, 1:45 PM), http://www.usnews.com/opinion/blogs/policy-dose/articles/2016-02[https://perma.cc/QPL708/nih-wont-fund-human-embryo-gene-editing-but-others-will
X96V] (archived Jan. 29, 2017).
Although an in-depth discussion of the federal government's Commerce
171.
Clause authority is outside of the scope of this Note, the Commerce Clause states that
Congress shall have power "[t]o regulate Commerce with foreign Nations, and among the
several States, and with the Indian Tribes." U.S. CONST. art. I, § 8, cl. 3. Embryonic
research likely falls under such commerce as it can lead to cures for disease and disorders
which could have a financial impact on millions, or even billions of dollars. For a further
discussion on the legislative authority to regulate research, see Lauren Thuy Nguyen,
Comment, The Fate of Stem Cell Research and a Proposal for Future Legislative
Regulation, 46 SANTA CLARA L. REV. 419, 439 (2006).

784

VANDERBILT/OURNAL OF TRANSNATIONAL

LAW

[VOL, SO:757

their embryos, whether it be to remove a genetic disorder or even to
choose their child's eye color. Such consumer-parents may travel across
state lines to seek out doctors and facilities with such CRISPR-Cas9
capabilities, causing a large amount of money to flow across state lines.
While writing legislation on such a medically heavy and contentious
topic may seem daunting, the framework for the law is already in
existence. The FDA previously commissioned a report on mitochondrial
replacement techniques, a method of modifying the germline, which
outlined recommendations for the FDA.1 72 Several contents of this
report, in particular the precursory stipulations to initial
investigations, should be combined with the licensing system and
limitations of the United Kingdom's regulation. Prohibition of
implantation of any genetically modified embryos eliminates the fear
of the rise of the "designer baby," as does the requirement to destroy
the embryo after fourteen days. Implementing a licensing system
ensures that regulatory oversight is in place, which the NIH will
control. 173 Further, the general legislation should control all research
initiatives, whether private or public, regardless of funding.
One obvious concern in regard to this proposal, however, is the
current attitude of the Supreme Court in interpreting the Commerce
Clause. Recent decisions, including Morrison, illustrate that the Court
has moved away from "the post-New Deal permissiveness" in
interpreting the Commerce Clause. 174 The Court's current stance is
that the federal government should leave truly local, noneconomic
conduct to the states.1 75 In Morrison, examples of such conduct
included "marriage, divorce, and childrearing," leading some critics to
believe that Commerce Clause restrictidns on certain types of genetic
research would be deemed unconstitutional. i76 Further, while

172.
See Zachary Brennan, Expert Committee: FDA Should Allow Mitochondrial
Replacement Trials Under Certain Conditions, REG. AFFAIRS PROFL SOc'Y (Feb. 3, 2016),
http://raps.org/Regulatory-Focus/News/2016/02/03/24245/Expert-Committee-FDA-ShouldAllow-Mitochondrial-Replacement-Trials-Under-Certain-Conditions/ [https://perma.cc/
MVU8-TVAK] (archived Jan. 29, 2017). The recommendations will not be discussed in
length as they are numerous and speak specifically to MRT. Rather, they can be
incorporated into a new law focused more generally on embryonic genetic editing.
173.
One subgroup that the National Institutes of Health could have control the
licensing function is the already existing National Human Genome Research Institute
which "has funded and conducted research to uncover the role that the genome plays in
human health and disease." National Human Genome Research Institute (NHGRI), THE
NIH ALMANAC, NAT. INSTS. OF HEALTH, http://www.nih.gov/about-nih/what-we-do/nihalmanac/national-human-genome-research-institute-nhgri (last visited Jan. 29, 2017)
[https://perma.cc/8JNM-D6HJ] (archived Jan. 29, 2016).
174.
Robert A. Burt, Constitutional Restraints on the Regulation of Cloning, 9
YALE J. HEALTH POL'Y, L. & ETHICS 495, 504 (2009).
175.
Id.
176.
Id. ("Prohibition of reproductive cloning is clearly nothing more than
identification of an impermissible technique of 'childrearing'; and the destruction of
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scientific endeavors such as the cloning of embryos arguably suffice as
economic activity because they create a commodity,' 7 7 gene editing
merely modifies an embryo.
Nonetheless, if a court held such a restriction to be constitutional,
then, by imposing explicit limitations, it can placate the fears of the
public and scientific community that this research will lead to the
selection of eye-color or height, and instead focus on the research's
capabilities to cure diseases. Updating the U.S. stance on gene editing
ensures that the country can remain at the forefront of scientific
advances, in an ethical manner, and closes the loopholes that have
existed because of the regulatory division based on whether the
researchers receive federal funding.
B. Establishingan InternationalConsensus
In a utopian world, key counties involved in gene editing
could collaborate and enact a multilateral or plurilateral treaty,
prohibiting gene editing until further research occurs and the ethical
implications can be better understood. Ideally, a stand-alone treaty
involving China, the United Kingdom, and the United States would
eliminate any fear that gene editing will bypass ethical concerns to the
detriment of society. This would allow for explicit language and
purposeful drafting premised on the current state of affairs. Further, a
new treaty provides an opportunity to delineate specific enforcement
or revision provisions. A treaty could be attempted under the purview
of the World Trade Organization. As gene editing implicates patent
law, fertility treatments, and the development of medicine, one could
make an argument, albeit a reach, that CRISPR-Cas9 implicates
trade. But, a link to trade is too attenuated and few countries are
willing to adopt binding measures, 7 8 perhaps more so in the scientific
realm: each country wants to be the first to make a breakthrough in
the newest field of research, whether it be for financial opportunities
or pure prestige. Further, the current political climate hinders the
likelihood of negotiating such a treaty. U.S. President Donald Trump
is currently deciding whether to sign the executive order, Moratorium
on New Multilateral Treaties, which "calls for a review of all current

embryos involved in cloning research is based on the progenitor's decision to refrain from
childrearing-that is, from carrying embryos to term.").
177.
See Russell Korobkin, Stem Cell Research and the Cloning Wars, 18 STAN. L.
& POL'Y REV. 161, 178-79 (2007) ("Under Raich, creating an embryo would presumably
be considered an 'economic' activity because it entails the production of a commodity,
even if the production is for a non-commercial purpose such as basic scientific research.").
178.
Brochure of the Declaration: UniversalDeclarationon Bioethics and Human
Rights, UNESCO (2006), http://unesdoc.unesco.org/images/0014/001461/146180E.pdf
[https://perma.cc/4FHS-C769] (archived Feb. 3, 2017).
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and pending treaties with more than one other nation ... that are not
directly related to national security, extradition or international
trade."1 79 Still, the international community cannot allow countries to
continue ethically questionable research absent any guidelines or
measures.
In order to balance the goal of instituting some protective
measures against the reality that countries like China and the United
States are unlikely to submit to binding restraints, modifying an
already existing declaration, specifically the Universal Declaration on
the Human Genome and Human Rights, presents a practical and
realistic solution. 8 0
1. The Universal Declaration on the Human Genome and Human
Rights
Shortly after the establishment of the United Nations post-World
War II, a U.N. Conference convened in November of 1945 to found an
organization reflecting "the 'intellectual and moral solidarity of
mankind."1 81 Thirty-seven countries, including China, the United
Kingdom, and the United States, consequently established the United
Nations
Educational,
Scientific and Cultural Organization
(UNESCO).1 82 Nearly fifty years later, with the publicized emergence
of genetic research, UNESCO adopted The Universal Declaration on
the Human Genome and Human Rights on November 11, 1997.183 The
Declaration sets "out universal ethical standards on human genetics
research and practices, standards that seek to balance the freedom to
carry out genetic research with a need to shield human rights and
protect people from potential abuses deriving from such research."1 84
While the Declaration contains several provisions to which gene
editing may be applicable, this Note argues that the key provision in
solving the current gene-editing dilemma is Article 11:
Practices which are contrary to human dignity, such as reproductive cloning of
human beings, shall not be permitted. States and competent international

179.
Max Fisher, Trump PreparesOrders Aiming at GlobalFunding and Treaties,
N.Y. TIMES (Jan. 25, 2017), https://www.nytimes.com/2017/01/25/us/politics/unitednations-trump-administration.html [https://perma.cc/BLR7-GSUA] (archived Feb. 3,
2017).
180.
The Organization'sHistory, UNESCO, http://www.unesco.org/new/en/unesco/
about-us/who-we-are/history/ (last visited Feb. 3, 2017) [https://perma.cc/V3TD-VT7H]
(archived Feb. 3, 2017).
181.
Id.
182.
Id.
183.
See Harry Rothman, Disseminating the Principles of the Universal
Declarationon the Human Genome and Human Rights, 19 NEW GENETICS & Soc'Y 89,
90 (2000).
Id.
184.
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organizations are invited to co-operate in identifying such practices and in
taking, at national or international level, the measures necessary to ensure that
the principles set out in this Declaration are respected.185

One argument is that the language in the first sentence of Article
11 is extremely broad, prohibiting undefined "practices" if they "are
contrary to human dignity." This use of "such as", in providing the
example of cloning, further evidences this breadth. As Part III
discussed, historical precedence dictates, or at least strongly suggests,
that modifications of the human population undertaken to maintain or
establish an ideal would be "contrary to human dignity" because such
modifications relay that those who do not meet the prescribed ideal are
inferior. Thus, gene editing is arguably exactly the kind of practice that
Article 11 intends to cover. Further, the International Summit and the
Consensus Study align with the recommendation provided in the
second sentence of the provision. Holding a forum to discuss gene
editing and its ethical implications, co-sponsored by the three
prominent countries in the research field, reflects "co-operat[ion] in
identifying such practices and. . . taking, at national or international
level, the measures necessary to ensure that the principles set out in
this Declaration are respected." 186
This approach has an obvious limitation: it relies on an implicit
interpretation. While one can readily argue for gene-editing's
inclusion, it is inadvisable to leave something so ethically important to
mere interpretation. Countries may differ in their interpretations of
"human dignity." While many disability advocates caution against a
method of eliminating mental disabilities,18 7 some countries may view
such treatment as beneficial for society. With the possibility of such
differing interpretations, a more explicit approach is preferred.
2. Revising Article 11 of the Declaration
Rather than relying on an ambiguous interpretation of an already
unenforceable declaration, UNESCO should revise Article 11 to
contain an explicit provision prohibiting gene editing to eliminate any
ambiguity of the international consensus. This Note proposes
amending the first sentence to read, "Practices that are contrary to

185.
UNESCO, RECORDS OF THE GENERAL CONFERENCE: TWENTY-NINTH
SESSION: RESOLUTIONS 44 (1997), http://unesdoc.unesco.org/images/00 11/001102/110220e
.pdf [https://perma.cc/BBK5-TTZ6] (archived Feb. 20, 2017).
186.
Id.
See Erika Check Hayden, Should you edit your children's genes?, NATURE
187.
(Feb. 23, 2016), http://www.nature.com/news/should-you-edit-your-children-s-genes1.19432 [https://perma.cc/8XYC-2XP6] (archived Feb. 3, 2016) (discussing gene editing
as a possible treatment to eliminate future instances of mental disabilities).
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human dignity, such as germline genetic modifications and
reproductive cloning of human beings, shall not be permitted." In order
to make such a change, several steps would need to be taken.
The process for modifying a pre-existing declaration is relatively
straightforward. First, the General Conference determines whether an
elaboration of a current declaration should address a certain
question.1 88 Genetically modifying offspring easily should arise to such
a level. It is highly publicized and contested and has already led to an
international review via the International Summit. Second, the
General Conference must request that the Director-General submit a
draft declaration on a specified date.18 9 Due to the minor scale of this
change, the Director-General should easily meet any deadline. Third,
the General Conference "reviews and discusses the draft declaration,"
which is "adopted by a resolution of the General Conference."1 90 The
third step is theoretically the most contentious but nonetheless is quite
feasible. Most countries, particularly those at the forefront of gene
editing, prohibit or severely restrict gene editing. Additionally, a group
of independent experts has already requested that UNESCO ban gene
editing.' 9 1 Such a minor change in the phrasing of Article 11 is unlikely
to illicit a large amount of backlash. As the General Conference is likely
to adopt this revision, the only remaining step is that the DirectorGeneral then has the responsibility of disseminating the declaration
"as widely as possible."' 2
3. The Practicality of a Declaration
As previously noted, a treaty would likely be unsuccessful at
remedying the lack of an international consensus on gene editing, but
a declaration provides a solution far less adverse to a country's
autonomy. An obvious advantage of a declaration over a treaty is that
a declaration is not subject to ratification and is not binding on Member
States. "However, in view of the greater solemnity and significance of
a 'declaration,' it may be considered to impact, on behalf of the organ
adopting it, a strong expectation that Members of the international

188.
Multi-stage procedure for the elaboration,examination, adoptionand followup of declarations, charters and similar standard-setting instruments adopted by the
General Conference, UNESCO, http://portal.unesco.org/en/ev.php-URL ID=31286&URLDO
=DO TOPIC&URLSECTION=201.html (last visited Feb. 28, 2017) [https://perma.cc/
9WK9-MSPU] (archived Mar. 25, 2017) [hereinafter Multi-stage procedure]
189.
Id.
190.
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191.
UNESCO panel of experts calls for ban on "editing"of human DNA to avoid
unethical tampering with hereditary traits, UNESCO, http://en.unesco.org/news/unesco
-panel-experts-calls-ban-editing-human-dna-avoid-unethical-tampering-hereditary-traits
(last visited Feb. 3, 2017) [https://perma.cc/7YBK-6PMX] (archived Feb. 3, 2017).
192.
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community will abide by it."1 9 3 Thus, a declaration can indicate
international consensus, 194 absent the complexities and complications
necessary in drafting, enacting, and ratifying a treaty.
Despite the apparent benefits of a declaration, it would be amiss for
this Note to fail to address that such an instrument remains "soft law."
Many scholars consider declarations "soft law" because of their nonbinding nature;19 5 there is nothing truly stopping countries from noncompliance. Unlike a treaty, declarations lack any enforcement
mechanism. There is no option to bring those who have violated the
instrument to a court, such as the International Court of Justice, nor a
method of resolving disputes, such as the Dispute Resolution process
of the World Trade Organization. However, treaties suffer from their
own limitations. The most glaring limitation is that there is nothing
stopping a country from withdrawing from a specific treaty if they no
longer wish to abide by it. Further, hard law is expensive to enact and
can be "difficult to adapt to changing circumstances," which scientific
research falls under. 196
Therefore, while the Declaration on the Human Genome and
Human Rights may lack the teeth of a more binding instrument, it
affords flexibility in a rapidly advancing field and a faster method for
establishing an international norm against gene editing.
VII. CONCLUSION

Technological advances in gene editing and modification over the
past few years have been astonishing.197 Research suggests that these
advances could provide a myriad of societal benefits-including the
elimination of certain diseases and disorders. Still, many have reason
to be weary of jumping into a world of gene editing and modification
when there are few limits and little regulation on just how far it can
go. Should scientists eliminate blindness, deafness, and mental

193.
General Introduction to the Standard-Setting Instruments, UNESCO,
http://portal.unesco.org/en/ev.phpURLID=23772&URLDO=DO-TOPIC&URLSECTI
ON=201.html#name=3 (last visited Feb. 3, 2017) [https://perma.cc/HC72-P4DX]
(archived Feb. 3, 2017).
194.
See Noalle Lenoir, Comment, Universal Declarationon the Human Genome
and Human Rights: The First Legal and Ethical Framework at the Global Level, 30
COLUM. HUM. RTS. L. REV. 537, 550 (1999) ("The purpose of a declaration is therefore to
help achieve international consensus. UNESCO's decision to draft a declaration sought
to facilitate agreement among states in the sensitive and complex field of bioethics.").
195.
See Jacob E. Gersen & Eric A. Posner, Soft Law: Lessons from Congressional
Practice,61 STAN. L. REV. 573, 575 (2008) (noting the non-binding nature of soft law).
196.
Gregory C. Shaffer & Mark A. Pollack, Hard vs. Soft Law: Alternatives,
Complements, and Antagonists in InternationalGovernance, 94 MINN. L. REV. 706, 719
(2010).
See Cyranoski & Reardon, supranote 10.
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handicaps if they are able to? To some, this seems all too similar to
other attempts at removing imperfections in society. As discussed, this
is not the first time that the desire to enhance genetics has resulted in
ethical offenses. In the United States, Congress enacted, and the
Supreme Court upheld, sterilization laws.1 98 The legislation's main
purpose was to eradicate certain infirmities--criminality, mental
illness, et cetera-from the population. However, ex post, society and
science now better understand these "infirmities," particularly mental
illnesses, and even provides treatments that allow these individuals to
prosper. Another example discussed was the horrific actions under the
Nazi regime and the Holocaust. Yet again, society and a culture
decided that certain traits were polluting the race-including
Judaism.' 9 9 Both of these historical examples show that societal,
cultural, scientific, and ethical values can change.
The International Summit and the Consensus Study acted as a
promising first step in looking at the gene-editing technology
thoroughly to determine the next move transnationally. However, the
United States needs to address the ambiguities and holes within its
own laws and the international community must develop a consensus
against gene editing in embryos, at least for now. The Universal
Declaration on the Human Genome and Human Rights provides an
opportunity to establish such a consensus in an already existing
instrument. Further, the non-binding nature of declarations, and the
ease in their adoption and revision, eliminates the hesitation many
countries have in entering more formal instruments, such as binding
treaties, and provides flexibility to modify the declaration. This
solution ensures that ethical obligations will not unnecessarily hinder
science, but also that the international research community will not
take them lightly. Relying on soft law ensures that the international
consensus on gene editing can adapt as researchers better understand
the technology. This may not only prevent a resurgence of the mistakes
of our past, but may also allow for a future in which this new and
exciting technology could eradicate detrimental disabilities.
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